The PE Ratio as of November 2024 (TTM) for Selecta Biosciences, Inc. (SELB) is -3.04

According to Selecta Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.04. This represents a change of 16.88% compared to the average of -2.60 of the last 4 quarters.

Selecta Biosciences, Inc. (SELB) Historical PE Ratio (quarterly & annually)

How has SELB PE Ratio performed in the past?

The mean historical PE Ratio of Selecta Biosciences, Inc. over the last ten years is -51.75. The current -3.04 PE Ratio has changed 487.18% with respect to the historical average. Over the past ten years (40 quarters), SELB's PE Ratio was at its highest in in the June 2021 quarter at 25.99. The PE Ratio was at its lowest in in the September 2016 quarter at -8.35.

Selecta Biosciences, Inc. (SELB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Selecta Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Selecta Biosciences, Inc. (SELB) Average PE Ratio

How has SELB PE Ratio performed in the past?

The current PE Ratio of Selecta Biosciences, Inc. (SELB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Selecta Biosciences, Inc. (SELB) PE Ratio vs. Peers

How is SELB’s PE Ratio compared to its peers?

Selecta Biosciences, Inc.’s PE Ratio is less than Paratek Pharmaceuticals, Inc. (-1.91), greater than Corvus Pharmaceuticals, Inc. (-10.50), greater than Immutep Limited (-57.96), greater than Icosavax, Inc. (-15.78), greater than Checkpoint Therapeutics, Inc. (-3.48), less than Mustang Bio, Inc. (-0.32), less than Reviva Pharmaceuticals Holdings, Inc. (-1.19), less than Fortress Biotech, Inc. (-0.62), less than Kodiak Sciences Inc. (-1.70), less than Reviva Pharmaceuticals Holdings, Inc. (-1.19), less than Eyenovia, Inc. (-0.20), less than Cognition Therapeutics, Inc. (-0.50), less than TransCode Therapeutics, Inc. (-0.38), less than Gamida Cell Ltd. (-0.23), less than Rigel Pharmaceuticals, Inc. (118.09), greater than Geron Corporation (-13.39), less than ImmunoGen, Inc. (322.18), less than Cidara Therapeutics, Inc. (-1.10), less than Fortress Biotech, Inc. (-0.62),

Build a custom stock screener for Selecta Biosciences, Inc. (SELB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Selecta Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Selecta Biosciences, Inc. (SELB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Selecta Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.